Clinical Study of Yiqi Huoxue Jiedu Recipe in Treating Antibiotic-Resistant Pneumonia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100041933

Enrollment

Unknown

Registered

2021-01-10

Start date

2021-01-16

Completion date

Unknown

Last updated

2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic-resistant Pneumonia

Interventions

experiment group:Standard anti-infective treatment, specifically refer to "Guidelines for Diagnosis and Treatment of Chinese Adult Community Acquired Pneumonia (2018 Revised Edition)" + Yiqi Huoxue Ji

control group:Standard anti-infective treatment, specifically refer to "Guidelines for Diagnosis and Treatment of Chinese Adult Community Acquired Pneumonia (2018 Revised Edition)" + Placebo of Chines

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for severe pneumonia. 2. Meet the diagnostic criteria for Dyspnea of lung qi deficiency and phlegm and blood stasis transimpedance. 3. Sputum culture and drug sensitivity culture pan-resistant Klebsiella pneumoniae. 4. Aged 18-95 years, no gender limit. 5. The patient or legal representative know the content of the study and sign an informed consent form voluntarily.

Exclusion criteria

Exclusion criteria: 1. Women during pregnancy and lactation. 2. People with mental illness. 3. People with allergies or allergies to this drug. 4. Alcohol or drug users.

Design outcomes

Primary

Measure	Time frame
Sputum Culture + Drug Sensitivity;Score of TCM Syndrome Scale;28-day mortality rate;	—

Secondary

Measure	Time frame
SOFA score;APACHE II score;chest CT;	—

Countries

China

Contacts

Public ContactZhaoheng Liu

Beijing University of Chinese Medicine

zliu@bucm.edu.cn+86 15101002133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026